Galmed Pharmaceuticals (NASDAQ:GLMD) Upgraded at Wall Street Zen
Galmed Pharmaceuticals (NASDAQ:GLMD – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “sell” rating to a “hold” rating in a report released on Saturday. Separately, Maxim Group restated a “hold” rating on shares of Galmed Pharmaceuticals in a research note on Friday, April 4th. Read Our Latest Research Report […]
Galmed Pharmaceuticals (NASDAQ:GLMD – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “sell” rating to a “hold” rating in a report released on Saturday. Separately, Maxim Group restated a “hold” rating on shares of Galmed Pharmaceuticals in a research note on Friday, April 4th. Read Our Latest Research Report […]
